Plasma FABP4 is associated with liver disease recovery during treatment-induced clearance of chronic HCV infection
J.-B. Gorin, D. F. G. Malone, B. Strunz, T. Carlsson, S. Aleman, N. K. Björkström, K. Falconer, J. K. Sandberg
This study examines how plasma inflammatory markers change during DAA therapy for CHC, finding that FABP4 levels correlate with liver disease improvement.
bioRxiv · Dec 24, 2019Immunology